Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation

Journal of Lipid Research

Volumn 45, Issue 5, 2004, Pages 866-872

  Tremblay, André J ^a   Lamarche, Benoît ^a,b   Ruel, Isabelle L ^a,b   Hogue, Jean Charles ^a   Bergeron, Jean ^a   Gagné, Claude ^a   Couture, Patrick ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Apolipoprotein B 100; Gas chromatography mass spectrometry; Kinetic

Indexed keywords

APOLIPOPROTEIN B100; LEUCINE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; GENE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPOPROTEIN METABOLISM; METABOLIC RATE; NULL ALLELE; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR GENE;

ADULT; APOLIPOPROTEIN B-100; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, VLDL; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; KINETICS; LIPOPROTEINS; MALE; MUTATION; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 2142713910     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300448-JLR200     Document Type: Article

References (44)

1. Young, S. G. 1990. Recent progress in understanding apolipoprotein B. Circulation. 82: 1574-1594.
2. Pittman, R. C., T. E. Carew, A. D. Attie, J. L. Witztum, Y. Watanabe, and D. Steinberg. 1982. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J. Biol. Chem. 257: 7994-8000.
3. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
4. Horton, J. D., H. Shimano, R. L. Hamilton, M. S. Brown, and J. L. Goldstein. 1999. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J. Clin. Invest. 103: 1067-1076.
5. Twisk, J., D. L. Gillian-Daniel, A. Tebon, L. Wang, P. H. Barrett, and A. D. Attie. 2000. The role of the LDL receptor in apolipoprotein B secretion. J. Clin. Invest. 105: 521-532.
6. Janus, E. D., A. M. Nicoll, P. R. Turner, P. Magill, and B. Lewis. 1980. Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects. Eur. J. Clin. Invest. 10: 161-172.
7. Fisher, W. R., L. A. Zech, and P. W. Stacpoole. 1994. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm. Arterioscler. Thromb. 14: 501-510.
8. Soutar, A. K., N. B. Myant, and G. R. Thompson. 1977. Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia. Atherosclerosis. 28: 247-256.
9. Soutar, A. K., N. B. Myant, and G. R. Thompson. 1982. The metabolism of very low density and intermediate density lipoproteins in patients with familial hypercholesterolaemia. Atherosclerosis. 43: 217-231.
10. Cummings, M. H., G. F. Watts, M. Umpleby, T. R. Hennessy, J. R. Quiney, and P. H. Sonksen. 1995. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Atherosclerosis. 113: 79-89.
11. Zulewski, H., R. Ninnis, A. R. Miserez, M. W. Baumstark, and U. Keller. 1998. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100. J. Lipid Res. 39: 380-387.
12. Hobbs, H. H., M. S. Brown, D. W. Russell, J. Davignon, and J. L. Goldstein. 1987. Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N. Engl. J. Med. 317: 734-737.
13. Harris, J., and F. Benedict. 1919. A Biometric Study of Basal Metabolism in Man. Carnegie Institution, Washington, DC.
14. Moorjani, S., A. Dupont, F. Labrie, P.J. Lupien, D. Brun, C. Gagné, M. Giguère, and A. Bélanger. 1987. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism. 36: 244-250.
15. Havel, R. J., H. Eder, and J. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
16. Albers, J. J., G. R. Warnick, D. Wiebe, P. King, P. Steiner, L. Smith, C. Breckenridge, A. Chow, K. Kuba, S. Weidman, H. Arnett, P. Wood, and A. Shlagenhaft. 1978. Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin. Chem. 24: 853-856.
17. Kotite, L., N. Bergeron, and R. J. Havel. 1995. Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins. J. Lipid Res. 36: 890-900.
18. Zilversmit, D. B., and T. M. Shea. 1989. Quantitation of apoB-48 and apoB-100 by gel scanning or radio-iodination. J. Lipid Res. 30: 1639-1646.
19. Welty, F. K., A. H. Lichtenstein, P. H. Barrett, G. G. Dolnikowski, and E. J. Schaefer. 1999. Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes. Arterioscler. Thromb. Vasc. Biol. 19: 2966-2974.
20. Cobelli, C., G. Toffolo, D. M. Bier, and R. Nosadini. 1987. Models to interpret kinetic data in stable isotope tracer studies. Am. J. Physiol. 253: E551-E564.
21. Maugeais, C., K. Ouguerram, M. Krempf, P. Maugeais, J. Gardette, E. Bigot, and T. Magot. 1996. A minimal model using stable isotopes to study the metabolism of apolipoprotein B-containing lipoproteins in humans. Diabetes Metab. 22: 57-63.
22. Winkler, K., J. R. Schafer, B. Klima, C. Nuber, A. Sattler, I. Friedrich, W. Koster, A. Steinmetz, H. Wieland, and W. Marz. 1999. Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia. Atherosclerosis. 144: 167-175.
23. Parhofer, K. G., P. Hugh, R. Barrett, D. M. Bier, and G. Schonfeld. 1991. Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J. Lipid Res. 32: 1311-1323.
24. Aguilar-Salinas, C. A., P. H. Barrett, K. G. Parhofer, S. G. Young, D. Tessereau, J. Bateman, C. Quinn, and G. Schonfeld. 1995. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B. Arterioscler. Thromb. Vasc. Biol. 15: 71-80.
25. Cohn, J., D. Wagner, S. Cohn, J. Millar, and E. Schaefer. 1990. Measurement of very low density and low density lipoprotein apolipoprotein (apo) B-100 and high density lipoprotein ApoA-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J. Clin. Invest. 85: 804-811.
26. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
27. Liao, W., T. Y. Hui, S. G. Young, and R. A. Davis. 2003. Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. J. Lipid Res. 44: 978-985.
28. Gillian-Daniel, D. L., P. W. Bates, A. Tebon, and A. D. Attie. 2002. Endoplasmic reticulum localization of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc. Natl. Acad. Sci. USA. 99: 4337-4342.
29. Yamamoto, T., R. W. Bishop, M. S. Brown, J. L. Goldstein, and D. W. Russell. 1986. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science. 232: 1230-1237.
30. Hornick, C. A., T. Kita, R. L. Hamilton, J. P. Kane, and R.J. Havel. 1983. Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits. Proc. Natl. Acad. Sci. USA. 80: 6096-6100.
31. Tanaka, M., H. Otani, M. Yokode, and T. Kita. 1995. Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Atherosclerosis. 114: 73-82.
32. Millar, J. S., C. Maugeais, I. V. Fuki, and D.J. Rader. 2002. Normal production rate of apolipoprotein B in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 22: 989-994.
33. Uauy, R., G. L. Vega, S. M. Grundy, and D. M. Bilheimer. 1988. Lovastatin therapy in receptor-negative homozygous familial hypercholesterolemia: lack of effect on low-density lipoprotein concentrations or turnover. J. Pediatr. 113: 387-392.
34. James, R. W., B. Martin, D. Pometta, J. C. Fruchart, P. Duriez, P. Puchois, J. P. Farriaux, A. Tacquet, T. Demant, R. J. Clegg, A. Munro, M. F. Oliver, C. J. Packard, and J. Shepherd. 1989. Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J. Lipid Res. 30: 159-169.
35. Fisher, W. R., L. A. Zech, L. L. Kilgore, and P. W. Stacpoole. 1991. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer. J. Lipid Res. 32: 1823-1836.
36. Gaffney, D., L. Forster, M. J. Caslake, D. Bedford, J. P. Stewart, G. Stewart, G. Wieringa, M. Dominiczak, J. P. Miller, and C. J. Packard. 2002. Comparison of apolipoprotein B metabolism in familial defective apolipoprotein B and heterogeneous familial hypercholesterolemia. Atherosclerosis. 162: 33-43.
37. Gaudet, D., M. C. Vohl, P. Perron, G. Tremblay, C. Gagné, D. Lesiege, J. Bergeron, S. Moorjani, and J. P. Després. 1998. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation. 97: 871-877.
38. Moorjani, S., M. Roy, A. Torres, C. Bétard, C. Gagné, M. Lambert, D. Brun, J. Davignon, and P. Lupien. 1993. Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia. Lancet. 341: 1303-1306.
39. Gudnason, V., I. N. M. Day, and S. E. Humphries. 1994. Effect on plasma lipid levels of different classes of mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia. Arterioscler. Thromb. 14: 1717-1722.
40. Welty, F. K., A. H. Lichtenstein, P. H. Barrett, J. L. Jenner, G. G. Dolnikowski, and E.J. Schaefer. 2000. Effects of apoE genotype on apoB-48 and apoB-100 kinetics with stable isotopes in humans. Arterioscler. Thromb. Vasc. Biol. 20: 1807-1810.
41. Watts, G. F., P. Moroz, and P. H. Barrett. 2000. Kinetics of very-low-density lipoprotein apolipoprotein B-100 in normolipidemic subjects: pooled analysis of stable-isotope studies. Metabolism. 49: 1204-1210.
42. Hobbs, H. H., M. S. Brown, and J. L. Goldstein. 1992. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum. Mutat. 1: 445-466.
43. Torres, A. L., S. Moorjani, M. C. Vohl, C. Gagné, B. Lamarche, L. D. Brun, P. Lupien, and J. P. Després. 1996. Heterozygous familial hypercholesterolemia in children-low-density-lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations. Atherosclerosis. 126: 163-171.
44. Kita, T., M. S. Brown, D. W. Bilheimer, and J. L. Goldstein. 1982. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc. Natl. Acad. Sci. USA. 79: 5693-5697.